Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies

With advancements in gene editing technologies, our ability to make precise and efficient modifications to the genome is increasing at a remarkable rate, paving the way for scientists and clinicians to uniquely treat a multitude of previously irremediable diseases. CRISPR-Cas9, short for clustered r...

Descripción completa

Detalles Bibliográficos
Autores principales: Papizan, James B., Porter, Shaina N., Sharma, Akshay, Pruett-Miller, Shondra M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Department of Journal of Biomedical Research 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038529/
https://www.ncbi.nlm.nih.gov/pubmed/33349624
http://dx.doi.org/10.7555/JBR.34.20200096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038529/
https://www.ncbi.nlm.nih.gov/pubmed/33349624
http://dx.doi.org/10.7555/JBR.34.20200096

Ejemplares similares